Non-clinical services for the development of interventional agents for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93021F00007
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,749,885
Award facts
- Contract value 100% obligated
- $1,749,884.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Mattawan, MI, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$16,168 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,766,053 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 28, 2021, under the Nonclinical Services for Development of Interventional Agents IDIQ with a ceiling value of $1,749,884.95. The order funds nonclinical services for developing interventional agents for infectious diseases, with an ultimate completion date of January 31, 2023, and is priced on a cost-plus-fixed-fee basis.
Place of performance is Mattawan, MI. The order was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 closing of the period of availability.
Service Contract Inventory reporting shows government-invoiced labor of 0.1 FTEs and 189 contractor hours in the most recent reported fiscal year (FY2023), corresponding to a derived hourly rate of $803.16/hr. FY2022 invoiced $1.6 million across 1,636 contractor hours at $976.85/hr. Sri International self-performed all reported hours; no subcontractors were reported.
Quick answers
Who was awarded contract 75N93021F00007?
75N93021F00007 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 28, 2021.
How much is contract 75N93021F00007 worth?
The government has obligated $1,749,885 on 75N93021F00007.
Is contract 75N93021F00007 an order under another contract?
Yes. 75N93021F00007 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93021F00007 competed?
The extent of competition for 75N93021F00007 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award